TULA® - Trans Urethral Laser Ablation of Recurring Bladder Tumors
The ability of simultaneous vaporization and coagulation offers a simple and safe method with a minimal to non loss of blood. The laser procedure can be performed on an outpatient basis under local anesthesia or even without anesthesia and offers the advantage over the previous standard procedure that general anesthesia can be omitted.
Non-muscle invasive bladder tumor normally has a high recurrence rate, leading to multiple treatments. Elderly patients with multiple morbidities are not fit for conventional treatment under general anesthesia. TULA® DUAL offers a technique using flexible cystoscopy for the treatment of bladder tumor under local or even no anesthesia in outpatient settings.
biolitec is present at congresses and other important events worldwide. Here is an overview:
|11th ECIO - European Conference on Interventional Oncology |
in Nice, France
|03.11.2020||International TULA® Laser Workshop for Non-Muscle-Invasive Bladder Tumors |
St Peters Hospital, Guildford Road, London – Department of Urology, Dr. S. Agrawal
Please register at email@example.com
Max. 4 participants
More information can be found here.
|16.11.-19.11.2020||Medica 2020, Hall 10 Booth H46 |
in Dusseldorf, Germany
|04.02.-05.02.2021||ESU-ESOU Masterclass on Non-Muscle Invasive Bladder Cancer |
Laser Safety Course biolitec
Postponed to 09.07.-13.07.2021
|21st EAU - European Association of Urology Congress |
in Milan, Italy